Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Lynch

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
European Journal of Immunology|May 1, 1996
JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cellsD J Wilson, K A Fortner, D H Lynch, et al.
International Immunology|November 1, 1994
Regulation of apoptosis and T cell activation by Fas-specific mAbM R Alderson, T W Tough, S Braddy, et al.
Transplantation Proceedings|February 1, 1997
Blocking of the B7-CD28 pathway increases apoptosis induced in activated T cells by in vitro-generated CD95L (FasL) positive dendritic cellsL Lu, S Qian, P Hershberger, et al.
Lymphokine and Cytokine Research|October 1, 1992
Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF)D H Lynch, C Jacobs, D DuPont, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Inducible resistance to Fas-mediated apoptosis in primary B lymphocytesT L Rothstein, L C Foote, T J Schneider, et al.
Cell Death and Differentiation|October 31, 2002
HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentationZ Nie, B N Phenix, J J Lum, et al.
Cell Death and Differentiation|June 25, 1999
Dynamic correlation of apoptosis and immune activation during treatment of HIV infectionA D Badley, K Parato, D W Cameron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylationB Mollereau, M Deckert, O Déas, et al.
Blood|June 1, 1991
Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptorC A Jacobs, D H Lynch, E R Roux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Functional analysis of TRAIL receptors using monoclonal antibodiesT S Griffith, C T Rauch, P J Smolak, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
European Journal of Immunology|May 1, 1996
JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cellsD J Wilson, K A Fortner, D H Lynch, et al.
International Immunology|November 1, 1994
Regulation of apoptosis and T cell activation by Fas-specific mAbM R Alderson, T W Tough, S Braddy, et al.
Transplantation Proceedings|February 1, 1997
Blocking of the B7-CD28 pathway increases apoptosis induced in activated T cells by in vitro-generated CD95L (FasL) positive dendritic cellsL Lu, S Qian, P Hershberger, et al.
Lymphokine and Cytokine Research|October 1, 1992
Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF)D H Lynch, C Jacobs, D DuPont, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Inducible resistance to Fas-mediated apoptosis in primary B lymphocytesT L Rothstein, L C Foote, T J Schneider, et al.
Cell Death and Differentiation|October 31, 2002
HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentationZ Nie, B N Phenix, J J Lum, et al.
Cell Death and Differentiation|June 25, 1999
Dynamic correlation of apoptosis and immune activation during treatment of HIV infectionA D Badley, K Parato, D W Cameron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylationB Mollereau, M Deckert, O Déas, et al.
Blood|June 1, 1991
Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptorC A Jacobs, D H Lynch, E R Roux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Functional analysis of TRAIL receptors using monoclonal antibodiesT S Griffith, C T Rauch, P J Smolak, et al.
Pageof 11